Fingerprint
Dive into the research topics of 'Phase I study of oral lenalidomide in patients with refractory metastatic cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase I study of oral lenalidomide in patients with refractory metastatic cancer
William L. Dahut, Jeanny B. Aragon-Ching, Sukyung Woo, Tanyifor M. Tohnya, James L. Gulley, Philip M. Arlen, John J. Wright, Jurgen Ventiz, William D. Figg
Research output: Contribution to journal › Article › peer-review
51
Scopus
citations